InsiderStreet Equity Research

Produced by InsiderStreet.ai from live production data. It is not investment advice, not an offer or solicitation to buy or sell any security, and not a recommendation for any investor. Do not rely on it for any investment decision.

Last Close

$229.04

2026-10-16

Market Cap

$161.0B

Volume

3.5M

52-Wk High

$242.80

52-Wk Low

$160.93

Trailing PE

40.5

P/S

6.41

Gross Margin

58.5%

Net Margin

15.9%

ROE

8%

ROIC

5%

Piotroski

6/9

Altman Z

3.7

1-Yr Return

+9.4%

5-Yr Return

+90.9%

Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Within the Life Sciences segment, Danaher provides advanced instrumentation and solutions crucial for scientific research and development. This encompasses equipment like mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization tools, and microscopes, alongside genomics consumables and technologies vital for Gene and Cell Therapy. Additionally, it delivers bioprocess technologies, consumables, and related services, as well as sophisticated filtration, separation, and purification systems. Its diverse clientele includes pharmaceutical, biopharmaceutical, food and beverage, medical, and life sciences companies, in addition to universities, medical schools, research institutions, and various industrial manufacturers. The Diagnostics segment is dedicated to furnishing essential tools for healthcare. Its offerings range from comprehensive systems for chemistry, immunoassay, microbiology, and automation to products for hematology, molecular, acute care, and pathology diagnostics. This segment equips hospitals, physicians' offices, reference laboratories, and other critical care settings with clinical instruments, reagents, consumables, software, and support services for accurate patient diagnosis and management. The Environmental & Applied Solutions segment addresses a broad spectrum of industrial and resource management requirements. It supplies instrumentation, consumables, software, services, and disinfection systems critical for the analysis, treatment, and management of various water typesâincluding ultra-pure, potable, industrial, waste, ground, source, and ocean waterâacross residential, commercial, industrial, and natural resource applications. Furthermore, this segment delivers instruments, software, services, and consumables tailored for color and appearance management, packaging design and quality assurance, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. Established in 1969, the company was initially known as Diversified Mortgage Investors, Inc., before officially rebranding as Danaher Corporation in 1984. Its corporate headquarters are located in Washington, D.C.

SectorHealthcareIndustryMedical - Diagnostics & ResearchExchangeNYSEMarket Cap$161.0BEmployees60,000 (SEC-filed)CEORainer BlairIPO1978-12-29CountryUS

2200 Pennsylvania Avenue, NW, Washington, DC 20037-1701 · Tel 202 828 0850 · danaher.com

INSIDERSTREET SCORE65 / 100Street mean $228.89 (9 analysts, last qtr) — their number, not ours

INSIDER CONSENSUS SIGNALROUTINE SELLING — LOW SIGNAL$13M sold / 6 mo, zero open-market buys

1 Year vs S&P 500 · DHR +9.4% · S&P 500 +15.9% · spread -6.5pp

7 Years vs S&P 500 · DHR +90.9% · S&P 500 +189.9% · spread -99.0pp

Both charts indexed to 100 at the start of their window and drawn on a single shared scale, so the gap to the benchmark is the gap you see. Adjusted closes throughout.

This space intentionally left blank — the next section begins on the following page

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

INSIDERSTREET
SCORE65of 100

Score Breakdown

Profitability	50/100
Growth	54/100
Momentum	83/100
Quality	75/100
Earnings Quality	78/100
Balance Sheet	60/100
Value	46/100
Risk (safety)	80/100
Overall	65.3/100

Each component is a diagnostic reading on its own 0-100 scale. The overall score is computed separately from the underlying financials and is not the average of the rows above — components are not equally weighted and three of them (Momentum, Value, Risk) are derived partly from price rather than from the business.

Peer Comparison — IS Score

Symbol	IS Score
TMO	63
NTRA	50
A	71
IDXX	80
IQV	56
WAT	47
DHR	65

IS Score Trend — quarterly

14 quarters, 23 Q1 to 26 Q2. Peak 65 in 26 Q2, latest 65 — +0 since. Fell in 0 of the last 4 quarters. Dashed line marks 40 on the 0-100 scale.

BUSINESS QUALITY65 / 100IS Score 65.3 / 100 · +0.0 from peak of 65

Fundamental factor model, quarterly. Measures how the business is doing - not where the price is going.

PRICE STRUCTUREBULLISHTechnical Score 87 / 100 · Power +74 · 21 of 22 indicator votes bullish

Vote share across trend, momentum, volume, volatility and pattern families. Describes where the price is, not where it is going.

Both readings sit above the midpoint — business quality at 65 and price structure at 87 out of 100 — so they are not in conflict. The fundamentals and the tape are saying the same thing, which is the case in which either one alone would have been enough.

Trigger	Where it stands now	What it would mean
IS Score reaches 75 and holds two consecutive quarters	now 65.3	would move us up one band
IS Score stops falling - one quarter higher than the prior	last four: 58 → 59 → 62 → 65	the direction matters more than the level
Technical vote share back above 50%	now 100%	price structure no longer broken
Institutional holder count rises two quarters running	peak 2,320 → now 2,125	fewer institutions willing to hold is our clearest warning

We publish these so the view can be shown to be wrong. If none of them move and our reading does, we owe you an explanation.

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

This page is InsiderStreet's own reading, produced from the data in the rest of this document. It is not a price target and not investment advice. Analyst consensus and street price targets appear later under their own heading and are the street's numbers, not ours.

Site Convergence Score3 of 4top 4% of 29,420 symbols

Sources Aligned— of 3independent disclosures

Congress (180d)11 buys2026-06-16

Insider Buys (180d)0none disclosed

ETF Funds (30d)1293 up / 1131 downnet +162 funds

Institutions Added (13F)-61managers opening or increasing

Congressional and insider figures are disclosed purchases in the trailing 180 days; ETF figures are COUNTS OF FUNDS whose holding changed in 30 days, not dollars. Coincidence of separate disclosures, not coordination. An absent source means nothing qualifying was disclosed in its window.

Institutions holding — 12 quarters

Peak 2,320 · latest 2,125 (-195 from peak).

Quarter	Holders	13F shares	Value	Reported own%
2026 Q2	2,125	583.0M	$106.7B	82.7%
2026 Q1	2,186	572.0M	$103.1B	81.1%
2025 Q4	2,318	582.2M	$127.1B	82.5%
2025 Q3	2,149	573.3M	$105.5B	81.3%
2025 Q2	2,181	575.6M	$107.0B	81.6%
2025 Q1	2,227	575.2M	$110.1B	81.6%
2024 Q4	2,320	572.6M	$123.0B	81.2%
2024 Q3	2,283	571.2M	$148.5B	81.0%
2024 Q2	2,187	580.4M	$136.2B	82.3%
2024 Q1	2,206	590.1M	$139.6B	83.7%
2023 Q4	2,137	587.2M	$129.3B	83.2%
2023 Q3	2,096	658.6M	$137.4B	93.4%

How to read ownership above 100%. A 13F reports the positions a manager has investment discretion over, and where two or more managers share discretion over the same block, each one reports it. Summed across filers, the total can therefore exceed the shares actually outstanding without anything being wrong. We publish the figure as filed rather than netting it down, and flag separately any quarter where the arithmetic is not merely high but impossible.

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Insider	Role	Date	Type	Shares	Value	Post-Txn Owned
Comas Daniel L	director	2026-10-09	—	52,338	—	0
Rales Mitchell P	director, Chairman of Exec. Committee	2026-10-09	D-Return	500,000	—	53,228
Rales Steven M	director, Chairman	2026-10-09	D-Return	500,000	—	3,105,808
Muppaneni Shashanka	SVP, Chief Strategy Officer	2026-10-01	—	197	—	0
Moler Heathre T	SVP, Chief HR Officer	2026-10-01	—	540	—	0
Blair Rainer	director, President & CEO	2026-08-21	SELL	11,307	$2.46M	46,948
Blair Rainer	director, President & CEO	2026-08-21	SELL	39,193	$8.57M	7,755
Blair Rainer	director, President & CEO	2026-08-21	SELL	7,755	$1.70M	0

6-mo decomposition (Form 4)	Txns	Shares	Value	Signal weight
S — Open-market sales	4	59,613	$13.0M	Counted
M — Exercises (paired A/D)	3	9,894	$0.7M	None — mechanics
F — Tax withholding	11	5,814	$1.2M	None — compensation
G — Gifts	1	71,648	—	None
P — Open-market purchases	0	0	$0	Counted — none occurred

Monthly Net Insider Flow (000 shares)

Net of acquisitions minus dispositions, all Form 4 types.

Signal Summary

SignalRoutine Selling — Low Signal

Open-Market Sells$13.0M4 txns / 6 mo

Open-Market Buys$0.0M0 txns / 6 mo

ClusterNone active3+ insiders / 21 days

Filed	Filer	Shares registered	Est. proceeds
2026-08-21	Rainer M. Blair	58,255	$12.7M
2026-07-14	Schwieters John T	3,298	$0.7M
2026-05-01	Spoon Alan G	1,358	$0.2M
2026-02-19	Milosevich Gregory M	1,320	$0.3M
Trailing 12 mo	12 filings	1,335,233	$287M

Filed	Form	Reporting person	% of class	Shares
2026-04-29	SCHEDULE 13G	Vanguard Capital Management	6.69%	47.4M sh
2026-01-30	SCHEDULE 13G/A	The Vanguard Group	8.63%	61.0M sh

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Member	Chamber	Trade	Size band	Traded	Disclosed
Kevin Hern	House	SELL	$1,001 - $15,000	2026-09-02	2026-09-28
Kevin Hern	House	SELL	$1,001 - $15,000	2026-09-02	2026-09-25
Kevin Hern	House	SELL	$1,001 - $15,000	2026-09-02	2026-09-25
Sheldon Whitehouse	Senate	SELL	$1,001 - $15,000	2025-08-28	2025-09-03
Sheldon Whitehouse	Senate	SELL	$1,001 - $15,000	2025-08-28	2025-09-03
Sheldon Whitehouse	Senate	SELL	$1,001 - $15,000	2025-08-28	2025-09-02

House 12-Mo39 trades23 purchases

Senate 12-Mo3 trades0 purchases

CoverageSTOCK Act filings30-45 day disclosure lag

13F Filers (last complete Q)2,186

13F Shares572M81.1% of shares out

New / Closed166 / 257positions, QoQ

Increased / Reduced788 / 934positions, QoQ

Put/Call (13F)1.00option positions

Free Float89.0%626M sh

2.8 · Largest Reporting 13F Managers

Manager	Shares	Value
Montrusco Bolton Investments Inc.	912,150	$202M
Sustainable Growth Advisers, Lp	860,591	$191M
Davenport & Co Llc	801,278	$178M
Douglas Lane & Associates, Llc	456,372	$101M
Vontobel Holding Ltd.	369,201	$82M
Asr Vermogensbeheer N.V.	255,286	$57M

EDGAR 13F holdings as of 2026-09-30; filer values normalized to dollars.

2.9 · Top ETF & Fund Ownership

Fund	Weight	Position
VITSX	0.2%	$4.4B
VTSAX	0.2%	$4.4B
VSMPX	0.2%	$4.4B
VTI	0.2%	$4.4B
VFIAX	0.2%	$3.6B
VFFSX	0.2%	$3.6B

13F Filers Holding DHR — quarterly

Institutional Put/Call — quarterly

This space intentionally left blank — the next section begins on the following page

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Daily short-sale volume as % of volume reported in FINRA's short-sale file — a flow measure, not short interest; dashed = 50-day average.

Latest Session30.1%2026-10-15

20-Day Avg41.5%50-day 40.3%

TrendRising20d vs 50d

By Market CenterQ: 30% · N: 37% · B: 57%latest session

Weekly Notional ($B)

Where DHR Trades in the Dark

ATS Venue (4-wk)	Shares	Avg trade
Incr Intelligent Cross Llc	6.6M	65 sh
Sgmt Sigma X2	3.5M	56 sh
Ubsa Ubs Ats	3.1M	66 sh
Ebxl Level Ats	3.0M	40 sh
Mlix Instinct X	2.8M	84 sh
Mspl Ms Pool (Ats-4)	2.2M	149 sh

Where a dollar of Danaher Corporation revenue goes. All values FY2025 filings, live.

Region	Revenue	Share
Other developed markets	$12.0B	82%
CHINA	$2.6B	18%

This space intentionally left blank — the next section begins on the following page

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

DHR (live moat model)Peer median: TMO · NTRA · A · IDXX · IQV

Component scores from the live moat model. Peer median illustrative.

Moat score 34/100 — None; primary source Efficient Scale.

3.8 · Employees (SEC filings)

Officer	Title
Rainer Blair	Senior Advisor
Matthew R. McGrew	Executive Vice President
Matthew E. Gugino	Chief Financial Officer & Executive Vice President
Julie Sawyer Montgomery	President, Chief Executive Officer & Director

Revenue ($B)

EPS ($) — GAAP diluted actual, street-basis estimate

Actual bars are GAAP diluted EPS from the filed income statement; the lighter forward bars are street-basis consensus. The two are different measures and are not comparable quarter to quarter.

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Quarterly EPS — Actual vs. Consensus

Beats (>2%)6 of 6recent quarters

Avg Surprise+8.2%

Next Report2026-10-21

Income Quality1.66OCF ÷ net income

Beat Rate—%0 of 0 quarters

Current Streak0longest 0

Avg EPS Surprise—%median —%

Surprise Trend—last 4 vs prior 4

Period	EPS est.	EPS actual	EPS surprise	Rev est. ($M)	Rev actual ($M)	Rev surprise

Announcement dates to . Consensus as it stood at each report. Revenue surprise shown where both estimate and actual are filed. A beat record is history, not a forecast.

Profit Margins (%)

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Revenue by Segment — Stacked

Live segmentation data.

YoY Growth Heatmap — Income Lines

YoY growth	FY21	FY22	FY23	FY24	FY25
Revenue	+32.2%	-9.5%	-10.3%	-0.1%	+2.9%
Gross profit	+43.9%	-9.8%	-13.3%	+1.2%	+5.4%
Operating income	+86.7%	-6.4%	-29.9%	-1.8%	-0.9%
Net income	+76.4%	+12.1%	-33.9%	-18.2%	-7.3%

$B · FY ends	FY21	FY22	FY23	FY24	FY25
Revenue	29.5	26.6	23.9	23.9	24.6
Cost of revenue	11.5	10.5	9.9	9.7	9.6
Gross profit	18.0	16.2	14.0	14.2	15.0
R&D expense	1.7	1.5	1.5	1.6	1.6
SG&A expense	8.2	7.1	7.3	7.4	8.2
Operating income	8.1	7.5	5.3	5.2	5.1
EBITDA	10.0	9.5	7.5	7.3	6.9
D&A	2.2	2.1	2.2	2.4	2.4
Pretax income	7.6	7.1	5.0	4.6	4.2
Income tax	1.3	0.8	0.8	0.7	0.6
Net income	6.4	7.2	4.8	3.9	3.6
Diluted EPS ($)	8.61	9.64	6.38	5.29	5.04
Diluted shares (M)	737	737	743	737	711

Operating CF$6B

CapEx$1B

Free cash flow$5B

SBC$0B

Buybacks$3B

Net cash change$3B

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Balance Sheet — Full

$B	FY22	FY23	FY24	FY25
Cash & equivalents	6.0	5.9	2.1	4.6
ST investments	0.0	0.0	0.0	0.0
Receivables (net)	5.1	4.6	4.4	3.9
Total current assets	15.9	13.9	9.5	12.8
PP&E (net)	4.6	5.6	6.1	5.5
Goodwill + intangibles	57.1	62.4	59.1	61.0
Total assets	84.4	84.5	77.5	83.5
Accounts payable	1.9	1.8	1.8	1.8
Short-term debt	0.8	1.9	0.5	0.0
Deferred revenue	1.5	1.5	1.3	0.0
Total current liabilities	8.4	8.3	6.8	6.8
Long-term debt	19.1	16.7	15.5	18.4
Total liabilities	34.3	31.0	28.0	30.9
Shareholders' equity	50.1	53.5	49.5	52.5

Cash Flow Statement — Full

$B	FY22	FY23	FY24	FY25
Net income	7.2	4.2	3.9	3.6
D&A	2.2	2.2	2.4	2.4
Stock-based compensation	0.3	0.3	0.3	0.3
Working capital change	(1.5)	(0.4)	0.3	(0.7)
Operating cash flow	8.5	7.2	6.7	6.4
Capital expenditures	(1.2)	(1.4)	(1.4)	(1.2)
Investing cash flow	(2.2)	(7.1)	(2.0)	(1.2)
Buybacks	0.0	0.0	(6.0)	(3.1)
Dividends paid	(0.8)	(0.8)	(0.8)	(0.9)
Debt issuance / (repay)	(1.7)	(1.6)	(1.7)	1.0
Financing cash flow	(2.6)	(0.3)	(8.4)	(3.0)
Free cash flow	7.4	5.8	5.3	5.3

This space intentionally left blank — the next section begins on the following page

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Balance Sheet Structure ($B)

Cash Generation vs Capex ($B)

Left: what the balance sheet is made of — the gap between the assets bar and the liabilities bar is book equity. Right: whether the capex bar is covered by the operating-cash bar; where it is not, the difference was funded externally and free cash flow goes negative.

Ratio	FY21	FY22	FY23	FY24	FY25	TTM
PROFITABILITY
ROE	15.1%	15.1%	9.2%	7.6%	7.1%	8%
ROA	8.1%	8.6%	5.6%	4.8%	4.5%	4.3%
ROIC	10.2%	11.3%	6.9%	6.7%	6.6%	5.0%
Gross margin	61.0%	60.8%	58.7%	59.5%	60.9%	58.5%
Operating margin	27.3%	28.3%	22.1%	21.7%	20.9%	20.4%
Net margin	21.8%	27.1%	19.9%	16.3%	14.7%	15.9%
EBITDA margin	34.0%	35.6%	31.4%	30.5%	28.3%	30.2%
FCF margin	24.0%	24.4%	23.0%	22.2%	21.4%	—
VALUATION
P/E	32.89	24.01	35.90	43.19	45.04	40.5
P/B	4.69	3.46	3.20	3.40	3.10	3.1
P/S	7.18	5.72	6.80	7.05	6.62	6.41
P/FCF	29.96	23.49	29.58	31.80	30.94	29.5
EV/EBITDA	23.21	18.15	24.11	25.22	25.42	24.2
EV/Revenue	7.89	6.21	7.35	7.68	7.19	7.3
Earnings yield	3.0%	4.2%	2.8%	2.3%	2.2%	2.48%
FCF yield	3.3%	4.3%	3.4%	3.1%	3.2%	3.39%

Ratio	FY21	FY22	FY23	FY24	FY25	TTM
LEVERAGE & SOLVENCY
Current ratio	1.43	1.89	1.68	1.40	1.87	1.65
Quick ratio	1.09	1.56	1.37	1.05	1.51	1.25
Debt / equity	0.52	0.41	0.37	0.35	0.35	0.51
Debt / assets	28.0%	24.4%	23.1%	22.1%	22.1%	28.8%
Net debt / EBITDA	2.07	1.41	1.78	2.07	1.99	2.93
Interest coverage	32.53	38.71	19.38	17.71	16.97	—

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Ratio	FY21	FY22	FY23	FY24	FY25	TTM
EFFICIENCY
Asset turnover	0.37	0.36	0.30	0.29	0.31	0.27
Receivables turnover	6.74	6.92	6.26	6.40	6.60	6.3
DSO (days)	54	53	58	57	55	58
DPO (days)	73	67	64	66	68	64
Cash conversion cycle	61	70	89	84	79	108
GROWTH (YoY)
Revenue growth	32.2%	2.7%	-16.9%	-5.0%	2.9%	—
Net income growth	76.4%	12.1%	-33.9%	-18.2%	-7.3%	—
EPS growth	73.1%	11.0%	-34.0%	-17.2%	-3.9%	—
FCF growth	30.4%	4.3%	-21.5%	-8.4%	-0.7%	—
PER SHARE ($)
EPS (diluted, TTM)	8.71	9.67	6.39	5.29	5.08	5.68
Book value / share	61.17	67.16	71.69	67.20	73.89	74.55
Revenue / share	39.89	40.55	33.69	32.39	34.55	35.60
FCF / share	9.57	9.88	7.75	7.18	7.40	7.75
Cash / share	3.50	8.04	7.86	2.82	6.49	6.16
SHAREHOLDER RETURN & SCORES
Buyback yield	0.0%	0.0%	0.0%	3.6%	1.9%	2.09%
Altman Z-Score	4.61	4.47	4.59	4.97	4.50	3.7
Piotroski F-Score	7	7	4	6	6	6/9
Beneish M-Score	-2.43	-2.60	-2.71	-2.69	-2.73	-2.57

Model	Score	Zone	Note
Piotroski F-Score	6 / 9	Middling
Altman Z-Score	3.7	Safe (>2.99)	Safe
Income quality	1.66	Cash-backed	OCF ÷ net income
Beneish M-Score	-2.57	Non-manipulator	vs −2.22 threshold

DuPont Decomposition (TTM)	Value
Tax burden	0.84
Interest burden	0.94
Operating margin	20.1%
Asset turnover	0.29×
Financial leverage	1.66×
= ROE	8%

Growth Quality (live)	Value
Revenue stability	0.35
Earnings stability	0.63
Earnings persistence	0.93
Revenue CAGR 3y	-3.5%
EPS CAGR 3y	-12.8%
FCF CAGR 3y	-8.8%

This space intentionally left blank — the next section begins on the following page

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Buyback Yield2.09%

Dividend Yield0.66%

Total Shareholder Return2.77%cash yield

SBC / Revenue1.5%dilution pressure

Company	Mkt cap	P/E	ROE	Net margin	Rev growth	Piotroski	1-yr ret
TMO	$255.1B	37.1	14%	14.5%	+7.2%	7/9	+28.7%
NTRA	$56.7B	-289.3	-13%	-8.9%	+37.8%	6/9	+117.9%
A	$48.8B	34.0	21%	19.3%	+8.6%	7/9	+22.6%
IDXX	$44.1B	39.4	74%	27.8%	+12.8%	9/9	-12.1%
IQV	$43.9B	32.8	23%	5.9%	+8.2%	7/9	—
WAT	$42.9B	108.7	2%	-8.3%	+52.5%	5/9	—
ILMN	$39.6B	48.5	32%	17.9%	+4.9%	7/9	—
MTD	$32.5B	36.4	-736%	22.7%	+6.9%	8/9	—

1-yr returns computed from adjusted price history; peers without a tracked series show —.

Buy

43 Analysts

Str Sell (0)Sell (1)Hold (12)Buy (29)Str Buy (1)

Mean Target (qtr)$228.899 targets

Target vs. Price-0.1%last-quarter mean

Next Report2026-10-21street $1.92

Consensus estimates	Revenue mean	High / Low	EPS mean	High / Low	# EPS est.
FY2026	$26.36B	$26.46B / $26.21B	$8.50	$8.52 / $8.45	14
FY2027	$28.48B	$29.03B / $27.28B	$9.30	$9.41 / $9.18	14
FY2028	$30.35B	$31.17B / $29.68B	$10.23	$10.72 / $9.09	6

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Street Price Target — Trajectory

Window	Avg Target	vs. Price	# Targets
Last Month	$246.67	+7.7%	3
Last Quarter	$228.89	-0.1%	9
Last Year	$236.52	+3.3%	27
All Time	$269.74	+17.8%	62

Rolling mean of published targets vs. last close $229.04. Aggregated from StreetInsider, Benzinga, Pulse 2.0.

Third-Party Composite Rating

B

DCF

4/5

ROE

3/5

ROA

4/5

Debt/Eq

1/5

P/E

1/5

P/B

3/5

Independent quant composite as of 2026-10-16; components scored 1–5 (5 best). Shown for contrast with the InsiderStreet Score — methodologies differ.

DHR +9.4% vs S&P 500 +15.9% — spread -6.5pp

Sector — XLV +24.2%

Peer Set — indexed to 100

All series indexed to 100 at the start of the window, adjusted closes.

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Candlesticks with SMA 20/50 overlay, Bollinger (20,2σ) band, volume, and Wilder RSI(14) — computed from live daily OHLCV.

Moving Average	Value	Distance	% Distance	Signal
SMA 20	$221.33	+7.71	+3.48%	Above
SMA 50	$213.62	+15.42	+7.22%	Above
SMA 200	$200.61	+28.43	+14.17%	Above
EMA 9	$224.10	+4.94	+2.20%	Above
EMA 21	$220.18	+8.86	+4.02%	Above
EMA 50	$213.40	+15.64	+7.33%	Above
EMA 200	$203.51	+25.53	+12.54%	Above

Series and readings from the nightly technical-indicator history — identical data to the site's ribbon chart. Supertrend segments colored by direction.

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

TECHNICAL VERDICTBULLISHPower Score +7421 of 22 indicator votes bullish

Family Scores (site weights)

Trend 30%100

Momentum 25%100

Volume 20%81

Volatility 10%100

Patterns 15%38

This Week100% bullishof 11 price-based votes

4 Weeks Ago91%+9 pts since

12 Weeks Ago45%+55 pts since

ReadImprovingweek-over-week trajectory

Price vs SMA 20$221.33

Price vs SMA 50$213.62

Price vs SMA 200$200.61

EMA 9/21 Cross224.1/220.2

SMA 50/200Golden

ADX DirectionADX 31

Supertrend$212

Parabolic SAR$213

SMA Slope0.880

RSI62.7

Stochastic K/D85/79

StochRSI K/D68/58

Williams %R-18

CCI154

TSI vs Signal18.3

CMO25.4

ROC7.00%

OBV SignalAccum

Chaikin MF0.220

MFI48

Force Index5M

Elder Ray Bull11.75

RSI (14)30 oversold · 70 overbought

Stochastic %Kvs %D 79

Money Flowvolume-weighted RSI

ADXtrend strength · <20 weak

Williams %Rinverted scale

Level	Value	Level	Value
Pivot / R1 / R2	$230.41 / $234.11 / $236.71	S1 / S2	$227.81 / $224.11
Bollinger (20,2)	$211.57 – $231.09	Squeeze	Off
52-wk range	$160.31 – $241.35	Off 52-wk high	-5.1%
ATR (14)	$6.05 (2.6%)	Historical vol	29.6%

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

+0.1%Jan50%

-0.6%Feb45%

+1.3%Mar57%

+1.7%Apr45%

+0.6%May65%

+1.2%Jun55%

+3.0%Jul70%

+0.2%Aug55%

+0.5%Sep60%

+1.0%Oct65%

+3.3%Nov85%

+1.6%Dec65%

Sample: 20 years — treat short histories as suggestive, not statistical.

Computed from live weekly prices	DHR	S&P 500
Weekly volatility (σ, 1y)	4.28%	1.83%
Best / worst week (1y)	+9.7% / -10.8%	—
Max drawdown (5y, monthly)	-36.3%	—
1-week VaR (95%)	-8.3%	—
Beta (5y)	0.81	1.00

DHR EQUITY WEATHER (LIVE)PARTLY CLOUDY · +23

Trend+44

Momentum+52

Volume+44

Volatility-60

Breadth-30

MARKET REGIME (2026-10-16)NEUTRAL

VIX19.99Normal

Dow TheoryConfirmed Bearish

SPY / QQQ TSI7.2 / 4.7trend strength

Sector Strength46/100breadth average

Average sentiment of 282 stories, weekly buckets, −1 to +1.

This space intentionally left blank — the next section begins on the following page

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Overall+23.0+40.0 vs industry

Trend+44.0+51.3 vs industry

Momentum+52.1+79.1 vs industry

Volume+43.9+43.9 vs industry

Reading	DHR	Medical - Diagnostics & Research n=227	Healthcare n=5,272	All US symbols n=70,435
Overall	+23.0	-17.0	-24.0	-20.5
Trend	+44.0	-7.2	-25.6	-21.3
Momentum	+52.1	-27.0	-28.5	-15.8
Volume	+43.9	+0.0	-25.0	-3.8

Trend, momentum and volume are computed per company. Volatility and breadth are market-regime values shared by every symbol in the universe, so they are reported once under Market Regime rather than compared here - a company cannot differ from its sector on a constant.

Executive	Total comp	Structure
Rainer M. Blair, President and CEO	$20.9M	56% equity+incentive
Joakim Weidemanis, Executive Vice President	$8.5M	53% equity+incentive
Matthew R. McGrew, Executive Vice President	$7.5M	52% equity+incentive
Jose-Carlos Gutierrez-Ramos, Senior Vice Pre	$7.2M	52% equity+incentive
Georgeann Couchara, Senior Vice President, H	$5.2M	52% equity+incentive

Pillar (live disclosure scores)	Score
Environmental	55
Social	56
Governance	59
Composite ESG	56

Composite ESG Trend

Filed	8-K contents	Items
2026-10-13	Officer/Director Change; Other Events	5.02,8.01
2026-08-03	Officer/Director Change; Regulation FD; Other Events; Exhibits	5.02,7.01,8.01,9.01
2026-07-21	Earnings Release; Exhibits	2.02,9.01
2026-06-03	Financial Obligation; Other Events	2.03,8.01
2026-05-07	Officer/Director Change; Shareholder Vote; Exhibits	5.02,5.07,9.01
2026-04-29	Material Agreement; Other Events; Exhibits	1.01,8.01,9.01
2026-04-21	Earnings Release; Exhibits	2.02,9.01
2026-04-17	Material Agreement; Financial Obligation; Exhibits	1.01,2.03,9.01

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Methodology. Every figure originates in InsiderStreet's production data layer and is computed deterministically by the same engines that power insiderstreet.ai. This factsheet contains no model-written text. Sections without underlying data are omitted rather than estimated.

DISCLOSURES. This document is produced by InsiderStreet.ai from live production data. It is not investment advice, not an offer or solicitation to buy or sell any security, and not a recommendation tailored to any person. Data is sourced as of the dates shown and may no longer be current. InsiderStreet.ai is not a registered investment adviser or broker-dealer. Investing involves risk, including loss of principal. Past performance does not guarantee future results. Do not make any investment decision based on this document. © 2026 InsiderStreet.ai — all rights reserved. Redistribution prohibited.

Data domain	Source	Coverage for this report
Price & volume	market_db.historical_prices	52 rows
Fundamentals	income_statements_annual	6 rows · 2020 to 2025
Reported vs consensus	fact/earnings_calendar	24 rows · 2020-07-23 to 2026-04-21
Analyst estimates	dim/forward_estimates	3 rows · 2026-12-31 to 2028-12-31
Institutional ownership (13F)	holdings_db.institutional_ownership_summary	114 rows · 1998 to 2026
Insider transactions (Form 4)	edgar/form4	12 rows · 2026-08-04 to 2026-10-09
Proposed sales (Form 144)	edgar/form144	1 record
Beneficial ownership (13D/G)	edgar/13dg	2 rows · 2026-01-30 to 2026-04-29
Short-sale volume (FINRA)	edgar/short_volume_daily	60 rows · 2026-07-23 to 2026-10-15
Dark pool (ATS, tier 1)	edgar/darkpool_weekly	12 rows · 2026-06-15 to 2026-08-31
ETF & fund holding	etf_holdings_changelog (30d)	1 record
Peer set	stock_peers_dynamic	8 rows
Industry medians	industry_medians	1 record
Congressional trades	congress_db (House + Senate)	1 record
ESG	fact/esg_disclosures	1 record

Method. Every figure in this factsheet is looked up from a named field computed in code. It contains no model-written text.

Not covered. Short interest as a percent of float and days-to-cover are not in this data set — the short-sale figures above are FINRA volume, a flow, and cannot support squeeze or covering analysis. Options positioning and intraday data are also absent. 13F ownership is filed 45 days after quarter end and congressional trades are disclosed on a lag, so both describe a past position, not a current one.

Danaher Corporation (DHR)

Danaher Corporation (DHR)

Score Breakdown

Peer Comparison — IS Score

IS Score Trend — quarterly

Danaher Corporation (DHR)

Institutions holding — 12 quarters

Danaher Corporation (DHR)

Monthly Net Insider Flow (000 shares)

Signal Summary

Danaher Corporation (DHR)

2.8 · Largest Reporting 13F Managers

2.9 · Top ETF & Fund Ownership

13F Filers Holding DHR — quarterly

Institutional Put/Call — quarterly

Danaher Corporation (DHR)

Where DHR Trades in the Dark

Danaher Corporation (DHR)

3.8 · Employees (SEC filings)

Danaher Corporation (DHR)

Danaher Corporation (DHR)

Danaher Corporation (DHR)

Balance Sheet — Full

Cash Flow Statement — Full

Danaher Corporation (DHR)

Danaher Corporation (DHR)

Danaher Corporation (DHR)

Danaher Corporation (DHR)

Street Price Target — Trajectory

Third-Party Composite Rating

Danaher Corporation (DHR)

Danaher Corporation (DHR)

Family Scores (site weights)

Danaher Corporation (DHR)

Danaher Corporation (DHR)

Danaher Corporation (DHR)